Zapanti Evaggelia, Polonifi Aikaterini, Kokkinos Michalis, Boutzios George, Kassi Georgia, Nasiri Ansari Narjes, Kassi Eva, Polyzos Aris
First Endocrine Department, Alexandra Hospital, Athens, Greece.
First Department of Internal Medicine, Laikon General Hospital, Athens University School of Medicine, Athens, Greece.
Hormones (Athens). 2015 Apr-Jun;14(2):321-5. doi: 10.14310/horm.2002.1586.
Inactivating mutations of the calcium-sensing receptor (CASR) gene cause familial hypocalciuric hypercalcaemia (FHH). Here we report three siblings with FHH caused by a novel mutation in the CASR.
The case subject was a 60-year-old patient referred because of mild hypercalcaemia, increased PTH levels and persistently low calcium/creatinine ratio. FHH was suspected and a family biochemical and genetic analysis was performed.
Sequencing of the CASR gene revealed a frameshift mutation (Val258Arg) in the extracellular domain of the CASR that creates a premature 46 amino acids stop codon which leads to a truncated protein that might affect its function. This heterozygous loss-of-function mutation in the CaSR gene causes reduced CaSR sensing ability resulting in the clinical manifestation of FHH.
We hereby report the identification of a novel heterozygous loss-of-function mutation of the CASR gene in a Greek family from Nisyros island. Functional studies are needed to clarify the exact role of this mutation in CASR activity.